Rifampicin-induced Stevens-Johnson Syndrome: A Rare Case Report
Tuberculosis (TB) continues to be a major global health issue, necessitating effective treatment regimens primarily involving antitubercular drugs. First-line antitubercular drugs are commonly used in combination with other medications to treat TB. These drugs are essential for the treatment of TB,...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JCDR Research and Publications Private Limited
2025-01-01
|
| Series: | Journal of Clinical and Diagnostic Research |
| Subjects: | |
| Online Access: | https://www.jcdr.net/articles/PDF/20464/76049_CE[Ra1]_F(SHU)_QC(AN_IS)_PF1(VD_SS)_PFA(NC)_PN(IS).pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841545842922618880 |
|---|---|
| author | Bhaveshkumar Manilal Patel Mugdha Manaji Kadam Arti Dhawal Shah Chirag Chakravarti Virenkumar Jayendrakumar Patel |
| author_facet | Bhaveshkumar Manilal Patel Mugdha Manaji Kadam Arti Dhawal Shah Chirag Chakravarti Virenkumar Jayendrakumar Patel |
| author_sort | Bhaveshkumar Manilal Patel |
| collection | DOAJ |
| description | Tuberculosis (TB) continues to be a major global health issue, necessitating effective treatment regimens primarily involving antitubercular drugs. First-line antitubercular drugs are commonly used in combination with other medications to treat TB. These drugs are essential for the treatment of TB, a contagious bacterial infection caused by Mycobacterium tuberculosis. However, antitubercular drugs can lead to various skin reactions, which may range from mild to severe. Stevens-Johnson Syndrome (SJS) is a rare and severe reaction characterised by extensive skin peeling and mucosal involvement. It can occur with any antitubercular drug but is more commonly associated with isoniazid and rifampicin. Rifampicin, an essential medication in the treatment of TB, is known for its efficacy but also for its potential to cause severe adverse reactions. The spectrum of skin reactions can vary widely, from benign rashes to Severe Cutaneous Adverse Reactions (SCARs), like SJS. Early recognition and appropriate management are crucial to mitigate complications. Understanding these adverse effects is essential not only for immediate patient care but also for fostering long-term adherence to TB treatment, as fear of side effects can lead patients to abandon their regimens prematurely. Hereby, the authors present a rare case of a 55-year-old male who developed life-threatening skin reactions, including SJS, following the initiation of rifampicin therapy. Rapid recognition and intervention were critical, leading to the immediate discontinuation of rifampicin and the initiation of supportive care and corticosteroids. The patient was closely monitored, and his condition improved significantly over the following weeks, with gradual resolution of skin lesions and restoration of mucosal integrity. |
| format | Article |
| id | doaj-art-8bd7e45afbae4b87950baa44084ec357 |
| institution | Kabale University |
| issn | 2249-782X 0973-709X |
| language | English |
| publishDate | 2025-01-01 |
| publisher | JCDR Research and Publications Private Limited |
| record_format | Article |
| series | Journal of Clinical and Diagnostic Research |
| spelling | doaj-art-8bd7e45afbae4b87950baa44084ec3572025-01-11T12:07:04ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2025-01-011901040610.7860/JCDR/2025/76049.20464Rifampicin-induced Stevens-Johnson Syndrome: A Rare Case ReportBhaveshkumar Manilal Patel0Mugdha Manaji Kadam1Arti Dhawal Shah2Chirag Chakravarti3Virenkumar Jayendrakumar Patel4Professor, Department of Respiratory Medicine, Sumandeep Vidyapeeth, SBKS Medical Institute and Research Centre, Vadodara, Gujarat, India.3rd Year Postgraduate Resident, Department of Respiratory Medicine, Sumandeep Vidyapeeth, SBKS Medical Institute and Research Centre, Vadodara, Gujarat, India.Professor and Head, Department of Respiratory Medicine, Sumandeep Vidyapeeth, SBKS Medical Institute and Research Centre, Vadodara, Gujarat, India.Assistant Professor, Department of Respiratory Medicine, Sumandeep Vidyapeeth, SBKS Medical Institute and Research Centre, Vadodara, Gujarat, India.Senior Resident, Department of Respiratory Medicine, Sumandeep Vidyapeeth, SBKS Medical Institute and Research Centre, Vadodara, Gujarat, India.Tuberculosis (TB) continues to be a major global health issue, necessitating effective treatment regimens primarily involving antitubercular drugs. First-line antitubercular drugs are commonly used in combination with other medications to treat TB. These drugs are essential for the treatment of TB, a contagious bacterial infection caused by Mycobacterium tuberculosis. However, antitubercular drugs can lead to various skin reactions, which may range from mild to severe. Stevens-Johnson Syndrome (SJS) is a rare and severe reaction characterised by extensive skin peeling and mucosal involvement. It can occur with any antitubercular drug but is more commonly associated with isoniazid and rifampicin. Rifampicin, an essential medication in the treatment of TB, is known for its efficacy but also for its potential to cause severe adverse reactions. The spectrum of skin reactions can vary widely, from benign rashes to Severe Cutaneous Adverse Reactions (SCARs), like SJS. Early recognition and appropriate management are crucial to mitigate complications. Understanding these adverse effects is essential not only for immediate patient care but also for fostering long-term adherence to TB treatment, as fear of side effects can lead patients to abandon their regimens prematurely. Hereby, the authors present a rare case of a 55-year-old male who developed life-threatening skin reactions, including SJS, following the initiation of rifampicin therapy. Rapid recognition and intervention were critical, leading to the immediate discontinuation of rifampicin and the initiation of supportive care and corticosteroids. The patient was closely monitored, and his condition improved significantly over the following weeks, with gradual resolution of skin lesions and restoration of mucosal integrity.https://www.jcdr.net/articles/PDF/20464/76049_CE[Ra1]_F(SHU)_QC(AN_IS)_PF1(VD_SS)_PFA(NC)_PN(IS).pdfantitubercular drugserythematous rashhyperpigmentationnikolsky signtuberculosis |
| spellingShingle | Bhaveshkumar Manilal Patel Mugdha Manaji Kadam Arti Dhawal Shah Chirag Chakravarti Virenkumar Jayendrakumar Patel Rifampicin-induced Stevens-Johnson Syndrome: A Rare Case Report Journal of Clinical and Diagnostic Research antitubercular drugs erythematous rash hyperpigmentation nikolsky sign tuberculosis |
| title | Rifampicin-induced Stevens-Johnson Syndrome: A Rare Case Report |
| title_full | Rifampicin-induced Stevens-Johnson Syndrome: A Rare Case Report |
| title_fullStr | Rifampicin-induced Stevens-Johnson Syndrome: A Rare Case Report |
| title_full_unstemmed | Rifampicin-induced Stevens-Johnson Syndrome: A Rare Case Report |
| title_short | Rifampicin-induced Stevens-Johnson Syndrome: A Rare Case Report |
| title_sort | rifampicin induced stevens johnson syndrome a rare case report |
| topic | antitubercular drugs erythematous rash hyperpigmentation nikolsky sign tuberculosis |
| url | https://www.jcdr.net/articles/PDF/20464/76049_CE[Ra1]_F(SHU)_QC(AN_IS)_PF1(VD_SS)_PFA(NC)_PN(IS).pdf |
| work_keys_str_mv | AT bhaveshkumarmanilalpatel rifampicininducedstevensjohnsonsyndromeararecasereport AT mugdhamanajikadam rifampicininducedstevensjohnsonsyndromeararecasereport AT artidhawalshah rifampicininducedstevensjohnsonsyndromeararecasereport AT chiragchakravarti rifampicininducedstevensjohnsonsyndromeararecasereport AT virenkumarjayendrakumarpatel rifampicininducedstevensjohnsonsyndromeararecasereport |